News
Latest news about Jerry Lanchbury - Stock Market | bentoncourier ...business.bentoncourier.com › news
business.bentoncourier.com
Data & News supplied by www.cloudquote.io. Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the ...
AZ deepens ties with Myriad on Lynparza companion test - PharmaTimes
www.pharmatimes.com
AstraZeneca has expanded its agreement with US group Myriad Genetics to identify women with advanced ovarian cancer most likely to benefit from its medicines....
Combined score enhances understanding of breast cancer risk
www.healio.com
SAN ANTONIO — A risk score based on clinical, familial and genetic factors improved 5-year and lifetime predictions of breast cancer risk among women who...
FDA Approves Myriad's myChoice® CDx Test to Help Identify ...apnews.com › ...
apnews.com
... GlaxoSmithKline on its FDA approval of Zejula for women with ovarian cancer,” said Jerry Lanchbury, Ph.D., chief scientific officer of Myriad.
sortiert nach Relevanz / Datum